Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-30
1996-04-02
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514266, 514262, 514261, 544267, A61K 3152, C07D47304
Patent
active
055040900
ABSTRACT:
Methods of preventing or inhibiting ischemia-reperfusion injury in an organ by administration of a composition containing a selective A.sub.1 adenosine receptor antagonist are provided.
REFERENCES:
patent: 4548818 (1985-10-01), Kjellen et al.
patent: 4593095 (1986-06-01), Synder et al.
patent: 4769377 (1988-09-01), Synder et al.
patent: 4772607 (1988-09-01), Badger et al.
patent: 4783530 (1988-11-01), Rzeszotarski et al.
patent: 4968672 (1990-11-01), Jacobson et al.
patent: 5032593 (1991-07-01), Rzeszotarski et al.
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5175290 (1992-12-01), Rzeszatarski et al.
patent: 5236908 (1993-08-01), Gruber et al.
patent: 5248678 (1993-09-01), Costa et al.
patent: 5256650 (1993-10-01), Peet et al.
patent: 5298508 (1994-03-01), Jacobson et al.
patent: 5366977 (1994-11-01), Pollard et al.
Drury AN, Szent-Gyorgi A., "The Physiological Activity of Adenine Compounds.sup.1 with Especial Reference To Their Action Upon The Mammalian Heart", J. Physiol (Lond) 68:213-237, 1929.
Burnstock G, "Cholinergic and Purinergic Regulation of Blood Vessels", Handbook of Physiology-The Cardiovascular System II, 2nd Edition, vol. 2, Chapter 19, pp. 567-612, 1979.
Ely, SW et al., "Functional and Metabolic Evidence of Enhanced Myocardial Tolerance to Ischemia and Reperfusion with Adenosine", J. Thorac Cardiovasc Surg 90:549-556, 1985.
Olafsson B, et al. "Reduction of Reperfusion Injury in the Canine Preparation by Intracoronary Adenosine: Importance of the Endothelium and the No-Reflow Phenomenon", Circ 76:1135-1145, 1987.
Lasley, RD, Mentzer, RM, "Adenosine Improves Recovery of Postischemic Myocardial Function Via an Adenosine A.sub.1 Receptor Mechanism", Am J Physiol 263:H1460-H1465, 1992.
Ely SW, Berne RM, "Protective Effects of Adenosine in Myocardial Ischemia", Circ 85:893-904, 1992.
Janier, MF, et al., "Adenosine Protects Ischemic and Reperfused Myocardium by Receptor-Mediated Mechanisms", Am J Physiol 264:H163-H170, 1993.
Zhao, ZQ, et al. "Receptor-Mediated Cardioprotective Effects of Endogenous Adenosine Are Exerted Primarily During Reperfusion After Coronary Occlusion in the Rabbit", Circ 88:709-719, 1993.
Brechler V et al., "Activation of Na.sup.30 /CA.sup.2+ Exchange by Adenosine in Ewe Heart Sarcolemma Is Mediated by a Pertussis Toxin-Sensitive G Protein", J Biol Chem 265:16851-16855, 1990.
Haselton FR et al., "Adenosine Decreases Permeability of In Vitro Endothelial Monolayers", J Appl Physiol 74:1581-1590, 1993.
Thornton JD, et al., "Intravenous Pretreatment With A.sub.1 -Selective Adenosine Analogues Protects the Heart Against Infarction", Ciur 85:659-665, 1992 (I).
Lui GS, et al., "Protection Against Infarction Afforded by Preconditioning is Mediated by A.sub.1 Adenosine Receptors in Rabbit Heart", Cir 84:350-356, 1991.
Thornton JD, "Effect of Adenosine Receptor Blockade: Preventing Protective Preconditioning Depends on Time of Initiation", Am J Physiol 265:H504-508, 1993, (II).
Toombs CF, et al., "Myocardial Protective Effects of Adenosine Infract Size Reduction With Pretreatment and Continued Receptor Stimulation During Ischemia", Circ 86:986-994, 1992.
Suzuki, F., et al., "Adenosine A.sub.1 Antagonists. 2. Structure-Activity Relationships on Diuretic Activities and Protective Effects against Acute Renal Failure", J. Med Chem, 35:3066-3075, 1992, (I).
Kellett, R. et al., "Amelioration of Glycerol-Induced Acute Renal Failure in the Rat with 8-cyclopentyl-1, 3-dipropylxanthine", Br. J. Pharmacol., 98:1066-1074, 1989.
Knight, R. J., et al., "Effect of the Selective A.sub.1 Adenosine Antagonist 8-cyclopentyl-1, 3-dipropylxanthine on Acute Renal Dysfunction Induced by Escherichia coli Endotoxin in Rats", J. Pharm Pharmacol., 45:979-984, 1993.
Neely et al. "Adenosine Does Not Mediate the Pulmonary Vasodilator Response of Adenosine 5'-triphosphate in the Feline Pulmonary Vascular Bed", J. Pharmacol. and Exp. Therap., 250(1):170-176, 1989.
Neely et al., "Adenosine and ATP Produce Vasoconstriction in the Feline Pulmonary Vascular Bed by Different Mechanisms", J. Pharmacol. and Exp. Therap., 258(3):753-761, 1991.
Adkins et al., "Adenosine Prevents PMA-induced Lung Injury Via an A2 Receptor Mechanism", Appl. Physiol., 1993, 74(3):982-988.
Egan TM, et al., Lung transplantation. Curr Probl Surg 26:675-751, 1989.
Levinson RM, et al., "Reperfusion Pulmonary Edema After Pulmonary Artery Thromboendarterectomy", Am Rev Resp Dis 134:1241-1245, 1986.
Kuratani T, et al., "Experimental Study in a Rabbit Model of Ischemia-reperfusion Lung Injury During Cardiopulmonary Bypass", J Thorac Cardiovas Surg 103:564-568, 1992.
Schmeling DJ, et al., "Evidence for Neutrophil-related Acute Lung Injury After Intestinal Ischemia-reperfusion", Surg 106:195-201, 1989.
Murata T, et al., "Reperfusion after a Two-Hour Period of Pulmonary Artery Occlusion Causes Pulmonary Necrosis", Am Rev Resp Dis 146:1048-1053, 1992.
Hamvas A, et al., "Inflammation and Oxygen Free Radical Formation During Pulmonary Ischemia-reperfusion Injury", J Appl Physiol 72:621-628, 1992.
Zamora CA, et al., "Thromboxane Contributes to Pulmonary Hypertension in Ischemia-reperfusion Lung Injury", J Appl Physiol 74:224-229, 1993.
Pharmacology and Physiological Roles. Edited by TW Stone, VCH, London, pp. 163-173, 1985.
Cronstein BN, et al., "Adenosine Modulates the Generation of Superoxide Anion by Stimulated Human Neutrophils via Interaction with a Specific Cell Surface Receptor", Ann NY Acad Sci 451:291-301, 1985.
Lambkin Deborah
Licata Jane Massey
Raymond Richard L.
Trustees of the University of Pennsylvania
LandOfFree
Compositions and methods for the prevention and treatment of isc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the prevention and treatment of isc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the prevention and treatment of isc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2016476